A syntenin-deficient microenvironment educates AML for aggressiveness
R. Leblanc, J. Fares, A. Goubard, R. Castellano, L. Camoin, M. Balzano, R. Ghossoub, B. Bou-Tayet, C. Fauriat, N. Vey, J.-P. Borg, Y. Collette, M. Aurrand-Lions, G. David, P. Zimmermann
Abstract
In acute myeloid leukemia (AML), the stromal microenvironment plays a prominent role in promoting tumor cell survival and progression. Although widely explored, the crosstalk between leukemic and stromal cells remains poorly understood. Syntenin, a multi-domain PDZ protein, controls both the trafficking and signaling of key molecules involved in intercellular communication. Therefore, we aimed to clarify the role of environmental syntenin in the progression of AML. By in vivo approaches in syngeneic mice, we demonstrate that a syntenin-deficient environment reprograms AML blasts to survive independently of the stroma. Up-regulation of EEF1A2 in the blasts controls this gain of cell survival. Furthermore, using ex vivo co-culture systems, we show that syntenin-deficient bone marrow stromal cells (BMSC) enhance the survival of different types of AML cells, including patient samples, and suffice to educate syngeneic AML, recapitulating micro-environmental effects observed in vivo. We establish that syntenin-deficiency causes an increase of eIF5A and autophagy-related factors in BMSC, and provide evidence that the inhibition of autophagy prevents syntenin-deficient BMSC to stimulate AML survival. Altogether, these findings indicate that host-syntenin in the BM microenvironment acts as a repressor of AML aggressiveness. Key points- A syntenin-deficient host reprograms AML blasts, enhancing total protein synthesis and cell survival pathways - Autophagy in the syntenin-deficient microenvironment is responsible for the gain of AML cell survival
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Downregulation of stromal syntenin sustains AML development
R. Leblanc, R. Ghossoub, … P. Zimmermann·bioRxiv·Feb 15, 2023
- Autophagy inhibition induces AML cell death and enhances the efficacy of chemotherapy under hypoxia
Eunice S. Wang, Hannah Fay, … Marianna C Giorgi·bioRxiv·Nov 24, 2024
- Overcoming treatment resistance mediated by the bone marrow vascular niche in acute myeloid leukemia
Matthew Froid, Sergio Branciamore, … David Basanta·bioRxiv·May 22, 2025
- A novel in-vitro model of the bone marrow microenvironment in AML identifies CD44 and Focal Adhesion Kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance
Eleni E Ladikou, K. Sharp, … Andrea G. S. Pepper·CancersPeer-reviewed·Jan 3, 2025
- Cell circuits between leukemic cells and mesenchymal stem cells block lymphopoiesis by activating lymphotoxin-beta receptor signaling
X. Feng, R. Sun, … J. P. Pereira·bioRxiv·Sep 23, 2022
- CD59 organizes the plasma membrane to sustain oncogenic Ras-MAPK signaling and is a targetable vulnerability in acute myeloid leukemia
Abdula Maher, Dhanoop Manikoth Ayyathan, … Steven M. Chan·bioRxiv·Aug 12, 2026